Historical record - last NADAC effective date: 7/17/2024
Product Information
MOMETASONE FUROATE 0.1% CREAM is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3964 per GM under NDC 68462019217. Its NADAC has been published 558 times since Nov 28, 2013.
FDA first approved this application on May 28, 2008.
Strength
1 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462019217
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
7/17/2024
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA078541FDA Approved
5/28/2008
On Market Since
5/28/2008
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 0.1% CREAM has been published 558 times since Nov 28, 2013, and over the history we have for it it has declined 5.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3964 per GM |
|---|---|
| All-time high | $0.8974 (Mar 13, 2019) |
| All-time low | $0.3064 (Apr 18, 2018) |
| Median price | $0.4684 |
| Average price | $0.4811 |
| Largest weekly change | +32.4% (Jun 19, 2024) |
| Weeks tracked | 558 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-13.9%
5Y
-28.1%
All
-5.2%
Last surveyed Jul 31, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 0.1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% CREAM, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3964 per GM (NDC 68462019217), effective Jul 31, 2024.
How has the price of MOMETASONE FUROATE 0.1% CREAM changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% CREAM has declined 5.2%. It has been tracked across 558 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% CREAM?
Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% CREAM has ranged from a low of $0.3064 (Apr 18, 2018) to a high of $0.8974 (Mar 13, 2019), with a median of $0.4684 per GM.
Are there cheaper alternatives to MOMETASONE FUROATE 0.1% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% CREAM, is $0.2959 per GM — about 25% below MOMETASONE FUROATE 0.1% CREAM.
Who manufactures MOMETASONE FUROATE 0.1% CREAM?
MOMETASONE FUROATE 0.1% CREAM (NDC 68462019217) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.